RxDoctor Payments Data

Tamara Grissell

Family · Castleton, NYNPI 1467495002

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 34.2% of the total. Reporting peaked in 2021 at $1,206 and has fallen 97.0% since, to $36 in 2025.

$2,649in general payments, 2019–2025

Across 143 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$906
  • Novo Nordisk$429
  • Mayne Pharma Commercial LLC$208
  • Exeltis, USA Inc.$166
  • Therapeuticsmd, Inc.$155
  • Sumitomo Pharma America, Inc.$154
  • plus $632 from 13 others

What the payments were for

  • Food & beverage$2,649100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,649 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.

See all family providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol11$1,071
ValacyclovirValacyclovir Hcl15$613

Paid to pharmacies, not to this prescriber.

Other family in Castleton

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →